BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dimitrova P, Ivanovska N. Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation. International Immunopharmacology 2008;8:1567-77. [DOI: 10.1016/j.intimp.2008.06.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Fenyo IM, Florea IC, Raicu M, Manea A. Tyrphostin AG490 reduces NAPDH oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein E-deficient mice. Vascular Pharmacology 2011;54:100-6. [DOI: 10.1016/j.vph.2011.03.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
2 Cheppudira BP, Girard BM, Malley SE, Dattilio A, Schutz KC, May V, Vizzard MA. Involvement of JAK-STAT signaling/function after cyclophosphamide-induced bladder inflammation in female rats. Am J Physiol Renal Physiol 2009;297:F1038-44. [PMID: 19625377 DOI: 10.1152/ajprenal.00110.2009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
3 Kok S, Hong C, Kuo MY, Wang C, Hou K, Lin Y, Galson DL, Lin S. Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: An implication for the pathogenesis of arthritis. Arthritis Rheum 2009;60:1451-62. [DOI: 10.1002/art.24452] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
4 Huang LS, Hung ND, Sok DE, Kim MR. Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory. Lipids 2010;45:225-36. [PMID: 20165929 DOI: 10.1007/s11745-010-3392-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
5 Li SF, Ouyang BS, Zhao X, Wang YP. Analgesic effect of AG490, a Janus kinase inhibitor, on oxaliplatin-induced acute neuropathic pain. Neural Regen Res 2018;13:1471-6. [PMID: 30106061 DOI: 10.4103/1673-5374.235305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Cheppudira BP, Garza TH, Petz LN, Clifford JL, Fowler M. Anti-hyperalgesic effects of AG490, a Janus kinase inhibitor, in a rat model of inflammatory pain. Biomed Rep 2015;3:703-6. [PMID: 26405549 DOI: 10.3892/br.2015.497] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
7 Gyurkovska V, Stefanova T, Dimitrova P, Danova S, Tropcheva R, Ivanovska N. Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice. Inflammation. 2014;37:995-1005. [PMID: 24473905 DOI: 10.1007/s10753-014-9820-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Martin EL, Ranieri VM. Phosphorylation mechanisms in intensive care medicine. Intensive Care Med 2011;37:7-18. [PMID: 20820992 DOI: 10.1007/s00134-010-2023-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Dimitrova P, Gyurkovska V, Shalova I, Saso L, Ivanovska N. Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490. J Inflamm (Lond) 2009;6:13. [PMID: 19416544 DOI: 10.1186/1476-9255-6-13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
10 Hung ND, Kim MR, Sok DE. Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis. Br J Pharmacol 2011;162:1119-35. [PMID: 21091644 DOI: 10.1111/j.1476-5381.2010.01117.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
11 Gyurkovska V, Ivanovska N. Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock. Eur J Pharmacol. 2015;751:118-126. [PMID: 25666385 DOI: 10.1016/j.ejphar.2015.01.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]